Human immunodeficiency virus test refusal in pregnancy: A challenge to voluntary testing

Daniela Carusi, Lee A. Learman, Samuel F. Posner

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: To determine if awareness of methods to reduce vertical transmission of human immunodeficiency virus (HIV) is associated with HIV test acceptance and to clarify patients' attitudes toward routine versus elective prenatal HIV testing. Methods: In a cross-sectional study, 247 antenatal patients were surveyed regarding HIV knowledge, self-perceived HIV risk, and willingness to learn a positive test result. This information, along with demographic and risk factor data, was related to HIV test acceptance. Patients also indicated their attitudes toward routine versus elective prenatal testing for HIV and other common prenatal screening tests. Results: Seventy-two percent of antenatal patients accepted HIV testing. Test acceptance was not associated with the presence of risk factors, self- perceived HIV risk, or demographic factors, including race and ethnicity. Test acceptance was associated positively with patients' knowledge of a medical intervention to reduce vertical transmission and their willingness to learn a positive HIV test result. Only 24% of patients knew that the risk of vertical transmission could be reduced using medication. Sixty-nine percent of patients said that prenatal HIV testing should be routine, whereas 27% said that it should be done only after specific written consent. As a group, our patients viewed HIV screening no differently from screening for other infections in pregnancy. Conclusion: Interventions aimed at increasing HIV testing rates among pregnant women should focus on educating patients about vertical transmission reduction and promising new therapies for HIV infection. Proponents of elective testing should re-evaluate the assumption that patients view HIV testing differently from other prenatal tests for which separate written consent is not required.

Original languageEnglish (US)
Pages (from-to)540-545
Number of pages6
JournalObstetrics and Gynecology
Volume91
Issue number4
DOIs
StatePublished - Apr 1998
Externally publishedYes

Fingerprint

HIV
Pregnancy
Demography
Virus Diseases
Prenatal Diagnosis
Pregnant Women
Cross-Sectional Studies

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Human immunodeficiency virus test refusal in pregnancy : A challenge to voluntary testing. / Carusi, Daniela; Learman, Lee A.; Posner, Samuel F.

In: Obstetrics and Gynecology, Vol. 91, No. 4, 04.1998, p. 540-545.

Research output: Contribution to journalArticle

Carusi, Daniela ; Learman, Lee A. ; Posner, Samuel F. / Human immunodeficiency virus test refusal in pregnancy : A challenge to voluntary testing. In: Obstetrics and Gynecology. 1998 ; Vol. 91, No. 4. pp. 540-545.
@article{eb23077cca2b48d1be8126bb61258e51,
title = "Human immunodeficiency virus test refusal in pregnancy: A challenge to voluntary testing",
abstract = "Objective: To determine if awareness of methods to reduce vertical transmission of human immunodeficiency virus (HIV) is associated with HIV test acceptance and to clarify patients' attitudes toward routine versus elective prenatal HIV testing. Methods: In a cross-sectional study, 247 antenatal patients were surveyed regarding HIV knowledge, self-perceived HIV risk, and willingness to learn a positive test result. This information, along with demographic and risk factor data, was related to HIV test acceptance. Patients also indicated their attitudes toward routine versus elective prenatal testing for HIV and other common prenatal screening tests. Results: Seventy-two percent of antenatal patients accepted HIV testing. Test acceptance was not associated with the presence of risk factors, self- perceived HIV risk, or demographic factors, including race and ethnicity. Test acceptance was associated positively with patients' knowledge of a medical intervention to reduce vertical transmission and their willingness to learn a positive HIV test result. Only 24{\%} of patients knew that the risk of vertical transmission could be reduced using medication. Sixty-nine percent of patients said that prenatal HIV testing should be routine, whereas 27{\%} said that it should be done only after specific written consent. As a group, our patients viewed HIV screening no differently from screening for other infections in pregnancy. Conclusion: Interventions aimed at increasing HIV testing rates among pregnant women should focus on educating patients about vertical transmission reduction and promising new therapies for HIV infection. Proponents of elective testing should re-evaluate the assumption that patients view HIV testing differently from other prenatal tests for which separate written consent is not required.",
author = "Daniela Carusi and Learman, {Lee A.} and Posner, {Samuel F.}",
year = "1998",
month = "4",
doi = "10.1016/S0029-7844(97)00714-X",
language = "English (US)",
volume = "91",
pages = "540--545",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Human immunodeficiency virus test refusal in pregnancy

T2 - A challenge to voluntary testing

AU - Carusi, Daniela

AU - Learman, Lee A.

AU - Posner, Samuel F.

PY - 1998/4

Y1 - 1998/4

N2 - Objective: To determine if awareness of methods to reduce vertical transmission of human immunodeficiency virus (HIV) is associated with HIV test acceptance and to clarify patients' attitudes toward routine versus elective prenatal HIV testing. Methods: In a cross-sectional study, 247 antenatal patients were surveyed regarding HIV knowledge, self-perceived HIV risk, and willingness to learn a positive test result. This information, along with demographic and risk factor data, was related to HIV test acceptance. Patients also indicated their attitudes toward routine versus elective prenatal testing for HIV and other common prenatal screening tests. Results: Seventy-two percent of antenatal patients accepted HIV testing. Test acceptance was not associated with the presence of risk factors, self- perceived HIV risk, or demographic factors, including race and ethnicity. Test acceptance was associated positively with patients' knowledge of a medical intervention to reduce vertical transmission and their willingness to learn a positive HIV test result. Only 24% of patients knew that the risk of vertical transmission could be reduced using medication. Sixty-nine percent of patients said that prenatal HIV testing should be routine, whereas 27% said that it should be done only after specific written consent. As a group, our patients viewed HIV screening no differently from screening for other infections in pregnancy. Conclusion: Interventions aimed at increasing HIV testing rates among pregnant women should focus on educating patients about vertical transmission reduction and promising new therapies for HIV infection. Proponents of elective testing should re-evaluate the assumption that patients view HIV testing differently from other prenatal tests for which separate written consent is not required.

AB - Objective: To determine if awareness of methods to reduce vertical transmission of human immunodeficiency virus (HIV) is associated with HIV test acceptance and to clarify patients' attitudes toward routine versus elective prenatal HIV testing. Methods: In a cross-sectional study, 247 antenatal patients were surveyed regarding HIV knowledge, self-perceived HIV risk, and willingness to learn a positive test result. This information, along with demographic and risk factor data, was related to HIV test acceptance. Patients also indicated their attitudes toward routine versus elective prenatal testing for HIV and other common prenatal screening tests. Results: Seventy-two percent of antenatal patients accepted HIV testing. Test acceptance was not associated with the presence of risk factors, self- perceived HIV risk, or demographic factors, including race and ethnicity. Test acceptance was associated positively with patients' knowledge of a medical intervention to reduce vertical transmission and their willingness to learn a positive HIV test result. Only 24% of patients knew that the risk of vertical transmission could be reduced using medication. Sixty-nine percent of patients said that prenatal HIV testing should be routine, whereas 27% said that it should be done only after specific written consent. As a group, our patients viewed HIV screening no differently from screening for other infections in pregnancy. Conclusion: Interventions aimed at increasing HIV testing rates among pregnant women should focus on educating patients about vertical transmission reduction and promising new therapies for HIV infection. Proponents of elective testing should re-evaluate the assumption that patients view HIV testing differently from other prenatal tests for which separate written consent is not required.

UR - http://www.scopus.com/inward/record.url?scp=0032054767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032054767&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(97)00714-X

DO - 10.1016/S0029-7844(97)00714-X

M3 - Article

C2 - 9540937

AN - SCOPUS:0032054767

VL - 91

SP - 540

EP - 545

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -